首页|康复新液灌肠联合美沙拉嗪对溃疡性结肠炎患者炎症反应及疾病复发情况的影响

康复新液灌肠联合美沙拉嗪对溃疡性结肠炎患者炎症反应及疾病复发情况的影响

扫码查看
目的 探讨康复新液灌肠联合美沙拉嗪对溃疡性结肠炎(UC)患者炎症反应及疾病复发情况的影响.方法 选取该院2020年1月—2023年1月收治的84例UC患者为研究对象,按随机数字表法将其分为对照组与观察组,各42例.对照组采用美沙拉嗪治疗,观察组在对照组基础上加用康复新液灌肠治疗.比较两组患者的临床疗效、炎症因子、氧化应激指标、不良反应发生率及疾病复发情况.结果 治疗后,观察组治疗总有效率为97.62%,高于对照组的80.95%,差异有统计学意义(P<0.05).治疗后,观察组白介素-6、C反应蛋白、肿瘤坏死因子-α水平均低于对照组,组间差异有统计学意义(P<0.05).治疗后,观察组超氧化物歧化酶水平高于对照组,过氧化脂质、一氧化氮水平均低于对照组,组间差异有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).随访6个月后,观察组疾病复发率为9.52%,低于对照组的33.33%,差异有统计学意义(P<0.05).结论 UC患者采用康复新液灌肠联合美沙拉嗪治疗的效果显著,可有效减轻患者机体炎症反应及氧化应激,降低疾病复发率,且较为安全.
Effect of Kangfuxin Fluid Enema Combined with Mesalazine on Inflammation and Disease Recurrence in Patients with Ulcerative Colitis
Objective To investigate the effects of Kangfuxin Fluid enema combined with mesalazine on inflammation and disease recurrence in patients with ulcerative colitis (UC).Methods A total of 84 UC patients admitted to the hospital from January 2020 to January 2023 were selected as the study objects, and were divided into a control group and an observation group according to random number table method, with 42 cases in each group.The control group was treated with mesalazine, and the observation group was treated with Kangfuxin Fluid enema on the basis of the control group.The clinical efficacy, inflammatory factors, oxidative stress indexes, adverse reactions and disease recurrence were compared between the two groups.Results The total effective rate of the observation group was 97.62%, higher than 80.95% of the control group, and the difference was statistically significant (P<0.05).After treatment, the levels of interleukin-6, C-reactive protein and tumor necrosis factor-α in the observation group were all lower than those in the control group, and the differences between the groups were statistically significant (P<0.05).After treatment, the level of superoxide dismutase in the observation group was higher than that in the control group, and the levels of lipid peroxide and nitric oxide were lower than those in the control group, the differences between the groups were statistically significant (P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).After 6 months of follow-up, the recurrence rate of the observation group was 9.52%, lower than 33.33%of the control group, and the difference was statistically significant (P<0.05).Conclusion The treatment of UC patients with Kangfuxin Fluid enema combined with mesalazine has significant effects, which can effectively reduce the inflammatory response and oxidative stress of patients, reduce the recurrence rate of disease, and is relatively safe.

Ulcerative colitisKangfuxin Fluid enemaMesalazineInflammatory responseDisease recurrence

李洪霞

展开 >

济南市钢城区人民医院内科,山东济南 271100

溃疡性结肠炎 康复新液灌肠 美沙拉嗪 炎症反应 疾病复发情况

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(15)